Related Experiment Video
Updated: May 26, 2026
11:13
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
Published on: September 14, 2013
Clostridium difficile in the ICU: the struggle continues.
Linda D Bobo1, Erik R Dubberke1, Marin Kollef2
1Adult Infectious Diseases Division, Washington University School of Medicine, St. Louis, MO.
Chest
|December 8, 2011
Summary
Clostridium difficile infection (CDI) is increasingly severe and costly. This review covers current guidelines and emerging strategies for managing this challenging healthcare-associated infection.
Area of Science:
- Infectious Diseases
- Epidemiology
- Healthcare Management
Background:
- Clostridium difficile infection (CDI) incidence and severity have risen significantly in hospital and community settings.
- This trend has led to increased healthcare costs, ICU admissions, and mortality.
- Challenges in CDI management include predicting severe cases, optimizing initial antibiotic choice, diagnostic limitations, evolving epidemiology, medication associations, and preserving gut microbiota.
Purpose of the Study:
- To present current management and prevention guidelines for CDI.
- To discuss potential new clinical strategies for CDI treatment and control.
Main Methods:
- Review of current literature and guidelines.
- Analysis of epidemiological trends and risk factors.
- Examination of emerging diagnostic and therapeutic approaches.
Main Results:
- Current guidelines from SHEA and IDSA provide a framework for CDI management.
- Several factors contribute to the increasing difficulty in managing CDI.
- New strategies are being explored to address diagnostic and treatment challenges.
Conclusions:
- Effective CDI management requires adherence to established guidelines.
- Addressing challenges in prediction, diagnosis, and treatment is crucial.
- Future strategies aim to improve patient outcomes and reduce the burden of CDI.
Related Concept Videos
01:22Healthcare Associated Infections II: Preventive Measures
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:26Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:17Urinary Tract Infection IV: Nursing Management
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...